Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules.

Hao, Yangyang; Choi, Yoonha; Babiarz, Joshua E; Kloos, Richard T; Kennedy, Giulia C; Huang, Jing; Walsh, P Sean

Hao, Yangyang; Choi, Yoonha; Babiarz, Joshua E; Kloos, Richard T; Kennedy, Giulia C; Huang, Jing; Walsh, P Sean.

Afiliação

Hao Y; Research and Development, Veracyte, South San Francisco, CA, United States.
Choi Y; Research and Development, Veracyte, South San Francisco, CA, United States.
Babiarz JE; Research and Development, Veracyte, South San Francisco, CA, United States.
Kloos RT; Medical Affairs, Veracyte, South San Francisco, CA, United States.
Kennedy GC; Research and Development, Veracyte, South San Francisco, CA, United States.
Huang J; Medical Affairs, Veracyte, South San Francisco, CA, United States.
Walsh PS; Department of Clinical Affairs, Veracyte, South San Francisco, CA, United States.

Front Endocrinol (Lausanne) ; 10: 438, 2019.

Article em En | MEDLINE | ID: mdl-31333584

Palavras-chave

Afirma GSC; RNA-Seq; analytical verification; clinical robustness; genomics; lab developed test; molecular diagnostics; thyroid cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google